Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of omeprazole on riociguat bioavailability and absorption in male volunteers

Trial Profile

Effects of omeprazole on riociguat bioavailability and absorption in male volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Omeprazole (Primary) ; Riociguat (Primary)
  • Indications Duodenal ulcer; Dyspepsia; Gastric ulcer; Gastritis; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Pulmonary arterial hypertension; Pulmonary hypertension; Raynaud's disease; Zollinger-Ellison syndrome
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Nov 2013 New trial record
    • 11 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top